PremiumCompany AnnouncementsLovesac Co. Earnings Call: Growth Amid Challenges Oracle reports Q4 beat, BioNTech to acquire CureVac: Morning Buzz Morning Movers: CureVac skyrockets after $1.25B deal to be acquired by BioNTech PremiumCompany AnnouncementsLovesac Elects Board Directors, Fails Compensation Approval Options Volatility and Implied Earnings Moves This Week, June 09 – June 12, 2025 Is LOVE a Buy, Before Earnings? PremiumThe FlyLovesac price target raised to $28 from $22 at Roth Capital Lovesac price target lowered to $30 from $45 at Canaccord Lovesac Reports Strong Q4 Earnings Amid Sales Decline